Sign in
IMMVF Stock Price, Chart, Stats & News
Immunovia AB
Save
Immunovia AB (IMMVF) does not currently pay a dividend.
6.11M
Market cap
–
Current P/E
–
Forward P/E
IMMVF chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Medical - Diagnostics & Research
Industry
Immunovia AB engages in the development of methods for diagnosing complex forms of cancer and autoimmune diseases. Its technology platform, IMMray, focuses on the early diagnosis of cancer, predicts disease progression, and monitors therapeutic responsiveness of cancers. The company was founded by Karl Arne Krister Borrebaeck on May 24, 2007 and is headquartered in Lund, Sweden.
Similar securities
Based on sector and market capitalization
Report issue